C1-inh as a drug for treating viruses pathogenic to humans

Details C1-inh as a drug for treating viruses pathogenic to humans C1-inh as a drug for treating viruses pathogenic to humans

A - Human Necessities

61

K

A61K 38/57 (2006.01) A61P 31/12 (2006.01) A61P 31/16 (2006.01)

Patent

CA 2535984

The C1 esterase inhibitor (C1-INH) from human plasma is a sialic-acid- containing glycoprotein which can bind other glycoproteins and glycolipids which may be components or even membrane components of microoganisms of viral and bacterial origin. In accordance with the invention, this binding can inhibit the penetration of certain viruses into target cells.

L'inhibiteur de l'estérase C1 (C1-INH) provenant du plasma humain est une glycoprotéine à base d'acide sialique qui peut se lier à d'autres glycoprotéines et à des glycolipides pouvant être des constituants ou même des constituants membranaires de micro-organismes d'origine virale et bactérienne. Selon l'invention, cette liaison peut inhiber la pénétration de certains virus dans des cellules cibles.

Affiliated with

Also associated with

Rating

C1-inh as a drug for treating viruses pathogenic to humans does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C1-inh as a drug for treating viruses pathogenic to humans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C1-inh as a drug for treating viruses pathogenic to humans will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1839289